6955 — Bonraybio Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Bonraybio Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	68.8	202	217	234	528
Net Total Accounts Receivable
Net Total Receivables	0.228	3.82	3.98	13.4	18.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	86.9	225	241	272	577
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	24	17	16.7	23.6	17.4
Net Intangible Assets
Other Long Term Assets
Total Assets	133	263	280	317	623
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	20.7	19.5	24.2	28.6	44.5
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	29.6	25.6	27.2	38.8	51.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	104	237	253	278	571
Total Liabilities & Shareholders' Equity	133	263	280	317	623
Total Common Shares Outstanding